Lv15
30 积分 2024-01-11 加入
Prognostic value of PSMA PET in predicting long‐term biochemical control following curative intent treatment for prostate cancer
8小时前
待确认
Personalized dosimetry assessment of [ 177 Lu]Lu-PSMA-617 radioligand therapy in the management of metastatic castration-resistant prostate cancer
22小时前
已完结
177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial
3天前
已完结
Survey of Clinical Protocols for the Use of177Lu-PSMA-617 in the United States
3天前
求助中
Correlation analyses of radiographic progression‐free survival with clinical and health‐related quality of life outcomes in metastatic castration‐resistant prostate cancer: Analysis of the phase 3 VISION trial
3天前
已完结
Clinical benefit and safety profile of cross-line therapy with CDK4/6 inhibitors: a retrospective study of HR+/HER2– advanced breast cancer
20天前
已完结
The Association of Interleukin‐36 Staining Intensity and Response to Biologic Therapy in Patients With Psoriasis: A Retrospective Immunohistochemical and Chart Review Pilot Study
21天前
已完结
Efficacy of Ixekizumab in Chinese Patients with Moderate-to-Severe Psoriasis and Special Body Area Involvement: Sub-analysis of a Randomized, Double-Blind, Multicenter Phase 3 Study
21天前
已完结
Coronary artery disease risk prediction by combined stratification of low‐density lipoprotein‐cholesterol and high‐density lipoprotein‐cholesterol levels across different glucose statuses
22天前
已完结
皖公网安备34019202002308
